Immunohematology Market Share, Growth, Trends and Report to 2025

Rising Prevalence of Hematological Disorders Fosters Growth in Immunohematology Market

Some of the most notable and prominent factors influencing the demand dynamics in the global immunohematology market include increasing awareness among the global population pertaining to the importance of blood donation as well as rising requirement for effective detection and diagnosis of blood related diseases.

Various public as well as private entities, along with various non-governmental organizations or NGOs are organizing awareness campaigns to underscore the importance of blood donation.

Report Overview: https://www.transparencymarketresearch.com/immunohematology-market.html

Several organizations are also promoting awareness regarding to the usage of safe blood and blood products. These trends are anticipated to work favorably for the enhancement of the global immunohematology market in coming years.

Rising prevalence of various hematological disorders i.e. diseases associated with blood as well as blood forming organs, is also expected to fuel the demand in the global immunohematology market in coming years. Some of the most notable types of hematological disorders are thalassemia, leukemia, sickle cell anemia, lymphoma, and hemophilia, among others.

For example, as per the study by the World Health Organization in 2020, around 4,74,519 new cases of leukemia were reported in 2020. Furthermore, more than 3,11,594 deaths were caused by leukemia in 2020. This rise in the prevalence of leukemia is anticipated to drive the demand for effective treatment and testing solutions in the global immunohematology market within the next few years.

Moreover, rising healthcare infrastructure upgradation, increase in expenditure on research and development for advancing the diagnosis as well as treatment of various hematological diseases, and favorable government policies and initiatives are also expected to foster the development in the global immunohematology market in the next few years.

Advancements in the global immunohematology market have paved way for automated hematological devices, high volume sample output, enhanced patient data management, software upgradation, and increase in the storage capacities. However, these technological advancements have also surged the costs of various devices and software tools in the global immunohematology market. The high cost associated with hematology equipment such as software and devices may hamper the growth in the global immunohematology market in coming years.

Request A Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=31544

Global Immunohematology Market: Snapshot
Rapid increase in the global disease burden and rise in the demand for blood- and plasma-derived products such as platelets, immunoglobulin, and plasma factors are augmenting the demand for immunohematology testing instruments and reagents. The number of patients with different hematological and other chronic diseases is also increasing rapidly across the world.

This is likely to raise the number of surgical procedures in the near future, consequently propelling the demand for blood transfusions. Demand for advanced immunohematology tests in also anticipated to increase during the forecast period in order to maintain the quality standards and safety profiles during blood transfusions.

Awareness among the general public regarding the importance of blood compatibility and transfusion-related diseases is increasing due to the development of health care infrastructure, government campaigns, and increasing per capita income in developed as well as developing countries. Awareness among patients about proper compatibility tests for transfusion is also increasing.

Increasing health care expenditure and rising worldwide concerns about medical safety are also driving the global immunohematology market. Moreover, government reimbursement programs in developed as well as developing countries are likely to provide growth opportunities to the immunohematology market in the near future.

Demand-supply gap of safe and adequate human blood and plasma is a major bottleneck in the blood transfusion & blood typing industry.

Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=31544

According to the World Health Organization, there is a significant difference between the blood demand-supply gap in developing countries and that in developed countries. Developed countries account for more than 50% of the global blood collections.

These countries represent only 19% of the global population. Supply disorders in both source materials and finished products, if not managed properly, can hamper the global immunohematology market during the forecast period.

Advancements in the immunohematology

technology have led to rapid development in the diagnostic approach toward in vitro study of the antigen-antibody interaction, facilitating improvement in the compatibility reaction between the donor's blood and the recipient's blood. Technological improvements in devices and reagents available for immunohematology testing have enabled clinicians to provide proper emergency assistance to patients.

These technological advancements include development of automated systems which make the identification process easier and provide more accurate results as compared to manual systems.

Request Report Methodology: https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=31544

Based on product, the global immunohematology market has been segmented into analyzers and reagents. The analyzers segment has been sub-segmented into automatic analyzers and semi-automatic/non-automatic analyzers.

Based on application, the global immunohematology market has been divided into blood typing and antibody screening. Based on end-user, the market has been classified into hospitals, academic & research institutes, diagnostic & reference laboratories, and blood banks.

The hospitals segment is expected to remain dominant during the forecast period, due to increasing usage of automated analyzers with high throughput in hospitals.

Geographically, the global immunohematology market has been segmented into five regions:

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2016 and is projected to continue its dominance between 2017 and 2025. Growth of the market in North America is primarily attributable to the increased funding by governments and the private sector and large volumes of blood transfusions. In addition, increased focus on research by pharmaceutical companies and well-established health care infrastructure are major factors driving the market in the region.

Request For Custom Research: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=31544

The market in Europe is projected to expand at a significant CAGR from 2017 to 2025.

Europe held the second-largest market share in 2016. High adoption and usage of superior-quality diagnostics and treatments is one of the major factors driving the market in the region. This can be attributed to increasing number of diagnostic laboratories and blood banks, rising government funding for research activities, and growing application of immunohematology in transfusion safety in the region.

Asia Pacific is one of the rapidly developing regions in the world. High per capita income has increased the consumption of blood products in the region.

Ask References: https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=31544

Key companies profiled in the report are Bio-Rad Laboratories, Inc., Grifols, S.A., Ortho Clinical Diagnostics, IMMUCOR, INC., Abbott Laboratories, Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Merck KGaA, and Siemens Healthineers. These players are adopting organic and inorganic growth strategies to expand their product offerings, enhance their geographical reach, widen their customer base, and gain market share. In 2016, Grifols, S.A. won a contract for supplying blood-typing solutions to the Red Cross of South Korea. The Malaysian National Blood Bank renewed its contract for Grifols's NAT technology that analyzes about 450,000 blood donations every year.

More Trending Reports by Transparency Market Research:

PRP and PRF in Cosmetics Market:
https://www.transparencymarketresearch.com/prp-and-prf-in-cosmetics-market.html

Fetal Bovine Serum Market: https://www.transparencymarketresearch.com/fetal-bovine-serum-market.html

Cell Culture Market: https://www.transparencymarketresearch.com/cell-culture-market.html

Bioprocess Technology Market: https://www.transparencymarketresearch.com/bioprocess-technology-market.html

Medical Waste Management Market: https://www.transparencymarketresearch.com/medical-waste-management-market.html

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims.
The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact Us

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

This release was published on openPR.